Abbott announced on 7 March it received US Food and Drug Administration clearance for a laboratory-based blood test used in hospitals to help clinicians assess mild traumatic brain injuries (TBI) in about 18 minutes.
A negative result rules out the need for a computed tomography (CT) scan and potentially long wait times in the emergency department.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?